What SPAS does

SPAS is a privately-held medical device company that has developed SPAS® (Stent Positioning Assistance System), a single-use mechanical accessory used in percutaneous coronary intervention (PCI) procedures. The device is a torque-like mechanism made of cast medical polymers that attaches to existing coronary stent delivery systems, enabling precise stent positioning through one-handed mechanical rotation with claimed accuracy at a fraction of 0.5mm. It is designed to be compatible with stent delivery systems from all major manufacturers and is positioned primarily for complex PCI procedures including bifurcation lesions, ostial lesions, chronic total occlusions, and acute myocardial infarction, where precise placement is difficult and time-to-stenting is critical.

The company's target customers are interventional cardiology departments in hospitals and cardiac catheterization laboratories. Its go-to-market is enterprise field sales — engaging directly with hospital management, interventional cardiologists, and procurement teams — supplemented by medical advisory board endorsements from key opinion leaders, clinical case publications, and website/video demonstrations. The revenue model is hardware sales of single-use consumable devices, generating repeat revenue per procedure performed. Pricing is not publicly disclosed and is assumed to be negotiated through hospital procurement contracts.

The company has completed a first-in-man clinical study at EMMS Hospital Nazareth (Israel) under Dr. Elias Hellou and is conducting additional clinical evaluations at ZNA Middelheim Hospital (Belgium) and Humanitas Gavazzeni Hospital (Italy). Its medical advisory board includes Prof. Antonio Colombo (40 years PCI experience, pioneer in DAPT and IVUS), Prof. Alberto Cremonesi, Dr. Pierfrancesco Agostoni, Dr. Giora Weisz (Columbia University), and Dr. Danny Dvir. Management includes CEO Marc van der Plas (former KPMG Corporate Finance Partner), Chief Strategy/Business Development Gerard Winkels (former Philips VP, ex-Corindus board member), Co-founder & CBO Inna Martin (former partner at a $760M venture project involving Domain Associates LLC), and Jeroen Kortsmit (PhD in Biomedical Engineering). No regulatory approvals (CE mark, FDA clearance), funding rounds, or commercial revenue figures are disclosed in the available source material.

Name

SPAS

Legal name

SPAS

Website

https://spas-system.com

Company type

Private

Founded year

2018

Operating status

Operating

Short description

SPAS is a private medical device company that has developed SPAS®, a single-use mechanical accessory for precise coronary stent placement in PCI procedures. It sells directly to interventional cardiology departments in hospitals, targeting complex cases including bifurcation lesions, ostial lesions, and CTOs.

Ownership category

akta.pro rank

Product category

Interventional Cardiology Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Peripheral Vascular Intervention (PAD Stents, Balloons, Atherectomy) (HLAHAFAE)

Keywords

• Coronary stent positioning
• Interventional cardiology devices
• Medical device accessories
• PCI procedure tools
• Single-use medical devices

Headquarters

HQ city

Not specified

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Marketing or Sales, Personnel

Revenue model

1. SPAS Device Sales: SPAS generates revenue through the sale of its single-use mechanical stent positioning devices to hospitals and interventional cardiology centres. As a consumable medical device used during coronary stenting procedures, revenue is derived from repeat purchases as procedures are performed.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

SPAS® is a single-use, mechanical torque-like accessory device used during percutaneous coronary intervention (PCI) procedures to enable precise positioning and repositioning of coronary stents. Made of cast medical polymers and compatible with stent delivery systems from all major manufacturers, it provides sub-millimetre placement accuracy via one-handed mechanical rotation, eliminating user-dependence and hand tremor during complex stenting.

Product overview

SPAS® is a single unified product — a mechanical accessory device for coronary stenting procedures. It is designed as a rotating handle mechanism that attaches to stent delivery systems, enabling precise millimeter and sub-millimeter positioning of stents through mechanical rotation. The device is made of cast medical polymers, compatible with coronary stent delivery systems of all major manufacturers, and is designed for single-use.

Differentiator

Problem solved

Functional benefit

Products and services

• SPAS® (Stent Positioning Assistance System) A single-use, mechanical torque-like accessory device for interventional cardiologists that enables precise (sub-0.5mm) positioning and repositioning of coronary stents during percutaneous coronary intervention (PCI) procedures via one-handed mechanical rotation. Made of cast medical polymers and compatible with all major coronary stent delivery systems, it eliminates user-dependent placement variability and hand tremor.

Quantifiable outcome

• Stent placement precision at a fraction of 0.5mm
• +2 more outcomes

Named customers4 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Emerging players

• Penumbra: Penumbra makes aspiration and thrombectomy catheters for vascular intervention, including coronary and peripheral applications. It shares SPAS's positioning as a fast-growing interventional cardiology/peripheral device company with a single-use consumable model and physician-driven adoption.
• Shockwave Medical: Shockwave Medical developed intravascular lithotripsy for calcium modification in coronary and peripheral interventions. It is a comparable emerging interventional cardiology company that built physician adoption and a recurring consumable revenue model — useful as a trajectory benchmark for SPAS.

Broad incumbents

• Abbott: Abbott manufactures the Xience and other coronary stent delivery systems that SPAS is designed to attach to. As the dominant coronary stent OEM, Abbott is the principal installed base SPAS would integrate with, but also the most likely incumbent to develop an in-house competing positioning solution or bundle.
• Philips: Philips operates the Image Guided Therapy business unit where SPAS CSO Gerard Winkels was formerly VP. Philips is a strategic neighbor in image-guided PCI workflows and a potential commercial/integration partner, while also being a candidate acquirer or competitor in cath-lab integration.
• Medtronic: Medtronic manufactures Resolute and Onyx coronary stent delivery systems and competes broadly across cardiovascular intervention. Its global coronary stent installed base is a target channel for SPAS, while its R&D scale makes it a likely source of competing precision-handle solutions.
• Boston Scientific: Boston Scientific manufactures Synergy and Promus coronary stent delivery systems and is a major OEM whose installed base SPAS targets. With deep interventional cardiology sales channels, Boston Scientific is both a critical commercial partner and a competitive threat if it ships its own positioning accessory.
• Edwards Lifesciences: Edwards Lifesciences is a structural heart and broader cardiovascular intervention incumbent with deep cath-lab relationships. While focused on transcatheter valves, its interventional cardiology salesforce could distribute SPAS as an adjunct product line, and its R&D could develop competing precision-handle solutions.
• Teleflex: Teleflex provides a broad portfolio of interventional cardiology and vascular access products sold through hospital channels. It serves as an example of a larger incumbent that could distribute or bundle a SPAS-like positioning accessory, and operates in the same cath-lab call points.

Direct peers

• Stereotaxis: Stereotaxis provides robotic magnetic navigation systems for catheter-based cardiac procedures, including PCI. It competes with SPAS in the positioning/navigation space for interventional cardiology, addressing similar physician pain points around precision and reduced radiation exposure.
• Corindus (Siemens Healthineers): Corindus (acquired by Siemens Healthineers) develops the CorPath robotic-assisted PCI platform for precise stent placement. It is the most direct functional peer to SPAS — both target sub-millimeter precision in stent positioning, though Corindus sells a capital robotic system while SPAS sells a single-use mechanical accessory. Gerard Winkels (SPAS CSO) was previously a Corindus board member.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SPAS